Seeking Alpha

Charles River Laboratories (CRL +6.4%) and Wuxi PharmaTech (WX) call off their merger agreement...

Charles River Laboratories (CRL +6.4%) and Wuxi PharmaTech (WX) call off their merger agreement following continued investor opposition. The $1.6B deal would have been the largest foreign takeover of a Chinese company; instead, Charles River will pay Wuxi a $30M breakup fee and begin a $500M share buyback program. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs